cbdMD, Inc. (YCBD)

Market Cap	743.71K
Revenue (ttm)	19.22M
Net Income (ttm)	-6.69M
Shares Out	782.85K
EPS (ttm)	-11.39
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	171,876
Open	0.8900
Previous Close	0.9350
Day's Range	0.8206 - 0.9500
52-Week Range	0.1700 - 1.0500
Beta	2.77
Analysts	n/a
Price Target	n/a
Earnings Date	May 15, 2025

About YCBD

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solution...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2015
• Employees: 42
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: YCBD
• Website: https://www.cbdmd.com

Financial Performance

In 2024, cbdMD's revenue was $19.48 million, a decrease of -19.35% compared to the previous year's $24.16 million. Losses were -$7.70 million, -71.40% less than in 2023.